Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corneal Changes in Breast Cancer Patients on Aromatase Inhibitors
NCT06924229Phase 4Completed
- Sponsor
- Sohag University
- Start
- Jun 2024
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in breast cancer, sponsored by Sohag University. Primary endpoints: Tear Break Up Time at 6 months and Schirmer Test at 6 months. Started Jun 2024; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06924229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06924229.